首页工具

登录

搜索结果

Search Results for " ret (v804m) "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T8467	RET V804M-IN-1 RETV804M kinase inhibitor,LUN09945	c-RET	Apoptosis; Tyrosine Kinase/Adaptors
	RET V804M-IN-1 (RETV804M kinase inhibitor) 是一种 wt-RET 选择性的RETV804M 激酶抑制剂，其IC50=20 nM。
T8222	Selpercatinib LOXO-292	c-RET	Apoptosis; Tyrosine Kinase/Adaptors
	Selpercatinib (LOXO-292) 是 RET 激酶抑制剂，抑制 RET (WT)、RET (V804M) 、RET (G810R)的 IC50分别为 14.0 nM、24.1 nM、530.7 nM，具有抗肿瘤活性。
TQ0277	Pralsetinib 普拉替尼,Blu667	c-RET	Apoptosis; Tyrosine Kinase/Adaptors
	Pralsetinib (Blu667) 是高效的、选择性的RET 抑制剂。它能够抑制 WT RET (IC50:0.4 nM)，RET 突变体 V804L (IC50:0.3 nM)，V804M (IC50:0.4 nM)，M918T (IC50:0.4 nM) 和 CCDC6-RET (IC50:0.4 nM) 的融合。
TQ0277L	Pralsetinib HCl (2097132-94-8 free base) Pralsetinib HCl,Pralsetinib hydrochloride,BLU-667,BLU667,BLU 667
	Pralsetinib is a selective and next-generation RET inhibitor (IC50: 0.3-0.4 nM for WT RET, RET mutants V804L, V804M, M918T, and CCDC6-RET fusion). BLU-667 is an effective and selective inhibitor of RET mutations, fusions, and predicted resistant mutants.
T40097	RET-IN-4
	RET-IN-4 is a highly effective and specific RET inhibitor that can be administered orally. It demonstrates remarkable potency, with IC50 values of 1.29 nM, 1.97 nM, and 0.99 nM for inhibiting RET variants including RET (WT), RET (V804M), and RET (M918T), respectively. Moreover, RET-IN-4 exhibits superior selectivity towards kinases JAK2 (IC50 of 4.4 nM) and FLT3 (IC50 of 30.8 nM). Additionally, RET-IN-4 possesses pronounced anticancer properties.
T16735	RET-IN-1	Others	Others
	RET-IN-1 is a RET kinase inhibitor (IC50s: 1 nM, 7 nM, and 101 nM for RET (WT), RET (V804M) , and RET (G810R), respectively).
T4301	AD80	Raf; c-RET; Src; S6 Kinase	Angiogenesis; Apoptosis; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors
	AD80 是多激酶抑制剂，可抑制 RET、RAF、SRC 和 S6K，并大大降低 mTOR 活性。
T78683	RET-IN-22
	RET-IN-22（compound 17b）是一种有效且选择性的口服活性RET抑制剂，其对野生型RET和RET-V804M的IC50分别为20.9 nM与18.3 nM。该化合物展现出对多数激酶，特别是EGFR和VEGFR2的高度选择性，表现出抗癌活性。
T73248	RET-IN-13
	RET-IN-13 是一种喹啉化合物，一种有效的 RET 抑制剂，对 RET(WT) 和 RET(V804M) 的 IC50分别为 0.5 nM 和 0.9 nM。RET-IN-13 具有用于与RET 异常激活相关的肿瘤或肠道疾病研究的潜力。
T64103	RET-IN-12
	RET-IN-12 是一种 RET 抑制剂，能够作用于 RET(WT) (IC50: 0.3 nM) 和 RET(V804M) (IC50: 1 nM)。
T73256	RET-IN-16
	RET-IN-16 是一种有效且具有选择性的RET 抑制剂，对RET(WT)，RET(M918T)，RET(V804L)，RET(V804M)，RET-CCDC6和RET-KIF5B 的IC50分别为 3.98 nM，8.42 nM，15.05 nM，7.86 nM，5.43 nM 和 8.86 nM。RET-IN-16 具有抗癌作用。
T79099	RET-IN-23
	RET-IN-23（化合物17）是一种有效的口服RET抑制剂，其IC50值对应RET-WT为1.32 nM、RET-CCDC6为2.50 nM、RET-V804L为6.54 nM、RET-V804M为1.03 nM及RET-M918T为1.47 nM。该化合物展现出了明显的抗肿瘤活性。
T63837	RET-IN-19
	RET-IN-19 是 RET 的有效抑制剂，能够作用于 RET-wt (IC50: 6.8 nM) 和 RET V804M (IC50: 13.51 nM)，表现出抗癌效果。RET-IN-19 能够用于研究非小细胞肺癌 (NSCLC)。
T39927	Zeteletinib hemiadipate BOS-172738 hemiadipate,DS-5010hemiadipate,Zeteletinib hemiadipate
	Zeteletinib hemiadipate (BOS-172738; DS-5010) is an orally active compound that functions as a selective inhibitor of RET kinase. It exhibits nanomolar potency against RET and a 300-fold selectivity towards VEGFR2. Notably, Zeteletinib hemiadipate demonstrates exceptional effectiveness against various forms of RET, including the wild type, RET V804M/L gatekeeper mutants, and the oncogenic RET mutation M918T. Additionally, Zeteletinib hemiadipate exerts potent antitumor effects.
T63468	RET-IN-14
	RET-IN-14 是 RET 的有效抑制剂，能够作用于 RET (WT) (IC50<0.51 nM)、RET (G810R) (IC50: 9.3 nM)、RET (V804M) (IC50: 1.3 nM)、BTK (C481S) (IC50: 9.2 nM) 和 BTK (C481S) (IC50: 15 nM)。RET-IN-14 表现出潜力进行肿瘤的研究。
T39688	Zeteletinib BOS-172738,DS-5010,Zeteletinib
	Zeteletinib (BOS-172738; DS-5010) is a highly potent and selective orally active inhibitor of the RET kinase. It demonstrates nanomolar potency against RET while exhibiting over 300-fold selectivity against VEGFR2. Zeteletinib exhibits remarkable efficacy against the wild-type RET, RET V804M/L gatekeeper mutants, as well as the frequently occurring oncogenic RET mutation M918T. Its antitumor activity is potent.

化合物

RET V804M-IN-1

Cat.No: T8467

Synonym: RETV804M kinase inhibitor,LUN09945

Target: c-RET

Cat.No: T8222

Synonym: LOXO-292

Target: c-RET

Cat.No: TQ0277

Synonym: 普拉替尼,Blu667

Target: c-RET

Pralsetinib HCl (2097132-94-8 free base)

Cat.No: TQ0277L

Synonym: Pralsetinib HCl,Pralsetinib hydrochloride,BLU-667,BLU667,BLU 667

Cat.No: T40097

Cat.No: T16735

Target: Others

Cat.No: T4301

Target: Raf, c-RET, Src, S6 Kinase

Cat.No: T78683

Cat.No: T73248

Cat.No: T64103

Cat.No: T73256

Cat.No: T79099

Cat.No: T63837

Zeteletinib hemiadipate

Cat.No: T39927

Synonym: BOS-172738 hemiadipate,DS-5010hemiadipate,Zeteletinib hemiadipate

Cat.No: T63468

Cat.No: T39688

Synonym: BOS-172738,DS-5010,Zeteletinib

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼